CELL & GENE THERAPY INSIGHTS

Raw and starting materials

Guest Editor:
Gary du Moulin, Consultant in Quality Systems and Compliance Strategies
Gary du Moulin
Consultant in Quality Systems and Compliance Strategies
March 2022